Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
CDC Warns Against Non-Pharmaceutical Use Of Chloroquine To Treat COVID-19 March 30, 2020 Martha Garcia Add Your Comments Federal regulators issued a health alert on Saturday, warning against the use of non-pharmaceutical chloroquine phosphate to treat COVID-19. The U.S. Centers for Disease Control and Prevention (CDC) Health Advisory was issued March 28, after chloroquine phosphate killed one person and severely injured another who took the chemical believing it could protect them from contracting the coronavirus disease 2019 (COVID-19). Chloroquine phosphate used without a prescription and not under the supervision of a doctor can lead to severe side effects, including death, the CDC warns. When used inappropriately or overdosed, the medication can lead to severe toxicity, including cardiac rhythm disturbances, such as prolonged QT, severe hypokalemia, cardiovascular collapse, seizures, coma, and death. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Two individuals, a husband and wife in their 60s, took non-pharmaceutical versions of chloroquine phosphate, in the form of fish tank cleaner, after hearing President Donald Trump describe the chemical as a possible treatment for COVID-19. The husband died after arriving at the hospital, and the wife was critically ill with severe gastrointestinal symptoms and cardiac conduction abnormalities. The wife reported to the media that they ingested the product to prevent infection with COVID-19 because they saw information on the medical use of chloroquine on television, specifically statements made by Trump. The couple feared getting sick and decided to take the substance. The product they used was powder form inside a 2.2 lb container and labeled “for Ornamental Fish Use Only.” Within 20 minutes of taking the chemical the couple became extremely ill and began vomiting and experiencing respiratory problems. Chloroquinephosphate and hydroxychloroquine are chemicals used in home aquariums and commercially available for purchase at stores and on the internet. There are unconfirmed media reports that the aquarium chemicals may be out of stock due to potential increased demand by the public because of statements made by government officials. However, there is currently no pharmaceutical products approved by the FDA to treat or prevent COVID-19. Furthermore, pharmaceutical chloroquinephosphate is approved by the FDA only to treat specific medical conditions, including malaria, lupus, and rheumatoid arthritis. Doses of the chemical can be toxic at levels not much higher than those used for treatment, which increase the risk of accidental overdose greatly, the CDC warns. Chloroquinephosphate and hydroxychloroquine are being studied as treatment for COVID-19, but there is no confirmed information the chemicals can treat the disease and those studies are in the beginning phases. President Trump defended his statements concerning the drug indicating people are dying and facing serious consequences either way. The CDC warns doctors and public health officials to discourage the public from misusing non-pharmaceutical chloroquine phosphate because of the severe side effects. There were more than 122,000 confirmed cases of COVID-19 in the Unites States as of March 29, with more than 2,100 deaths and the illnesses continue to climb. Globally, COVID-19 cases have reached nearly 723,000, sickening people in nearly every country and killing more than 33,000 people. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Chloroquine, Coma, Coronavirus, Death, Hypokalemia, Poison, Seizure Image Credit: | More Lawsuit Stories Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court November 17, 2025 Xcela Chemo Port Lawsuit Alleges Defective Catheter Device Caused Strep, Sepsis Infections November 17, 2025 FDA Reviewing Elevidys Black Box Warning About Acute Liver Injury Risk November 17, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: today) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025) GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 3 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025) Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 4 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)
Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court November 17, 2025
Xcela Chemo Port Lawsuit Alleges Defective Catheter Device Caused Strep, Sepsis Infections November 17, 2025
Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (Posted: today) Lawsuits over Ozempic and Wegovy vision loss will be consolidated for pretrial proceedings in New Jersey, separate from claims involving gastrointestinal injuries. MORE ABOUT: OZEMPIC LAWSUITJudge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges (10/21/2025)Ozempic, Wegovy Kidney Side Effects Highlighted in New Study (10/10/2025)
GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director (Posted: 3 days ago) Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks. MORE ABOUT: BREAST MESH LAWSUITBreast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits (11/10/2025)Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems (11/06/2025)Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures (10/27/2025)
Hair Relaxer Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: 4 days ago) A series of case management conferences have been scheduled for hair relaxer litigation throughout 2026, leading up to expected bellwether trials in 2027. MORE ABOUT: HAIR RELAXER LAWSUITUpdate on Hair Relaxer Lawsuit Status To Be Provided to Court at MDL Hearing (11/05/2025)Hair Relaxer Injury Lawsuit Against L’Oreal, Strength of Nature Cleared To Move Forward (10/20/2025)MDL Judge To Weigh Hair Relaxer Cancer Evidence in Mid-2026 (09/11/2025)